Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client-Owned Dogs: A Multicenter, Double-Masked, Randomised, Placebo-Controlled Clinical Trial
S. Forster, C.M. Trout, S. Despa, A. Boegel, D. Berger and S. King | Veterinary Dermatology | July 2025
The aim of this double-blinded randomised placebo-controlled study was to evaluate the efficacy and safety of ilunocitinib (a new Janus kinase inhibitor) in the control of pruritus in dogs with allergic dermatitis…
Connect with us